Modulating gut dysbiosis and mitochondrial dysfunction in oxazolone-induced ulcerative colitis: the restorative effects of β-glucan and/or celastrol

Autor: Omnia Safwat El-Deeb, Rasha Osama El-Esawy, Hanan Alsaeid Al-Shenawy, Heba Bassiony Ghanem

Publikováno v: Redox Report, Vol 27, Iss 1, Pp 60-69 (2022)

Objectives Microbiome–Mitochondria interaction is gaining a significant attention; thus, studying its mechanism emerges as a must to provide restorative lines in managing diseases. The aim is to study the mechanistic effects of β-Glucan and/or Cel

Externí odkaz: https://doaj.org/article/a1cb9c77242d42b08c6039d0c51774b5

Moderating Gut Microbiome/Mitochondrial Axis in Oxazolone Induced Ulcerative Colitis: The Evolving Role of β-Glucan and/or, Aldose Reductase Inhibitor, Fidarestat.

Autor: El-Deeb, Omnia Safwat¹ (AUTHOR) omnia.eldeeb@med.tanta.edu.eg, Elesawy, Rasha Osama² (AUTHOR), Eltokhy, Amira K.¹ (AUTHOR), Al-Shenawy, Hanan Alsaeid³ (AUTHOR), Ghanem, Heba Bassiony^1,4 (AUTHOR), Rizk, Fatma H.⁵ (AUTHOR), Barhoma, Ramez AE⁵ (AUTHOR), Shalaby, Rania H.^2,6 (AUTHOR), Abdelsattar, Amal M.⁷ (AUTHOR), Mashal, Shaimaa S.⁸ (AUTHOR), Eshra, Kareman Ahmed⁹ (AUTHOR), El-Sharaby, Radwa Mahmoud¹⁰ (AUTHOR), Ali, Dina Adam¹⁰ (AUTHOR), Ibrahim, Rowida Raafat¹ (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Feb2023, Vol. 24 Issue 3, p2711. 17p.

Study Data from Tanta University Provide New Insights into Ulcerative Colitis (Moderating Gut Microbiome/mitochondrial Axis In Oxazolone Induced Ulcerative Colitis: the Evolving Role of Beta-glucan And/or, Aldose Reductase Inhibitor, Fidarestat).

Publikováno v: Gastroenterology Week; 4/4/2023, p702-702, 1p